Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 39 citing articles:

Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment
Safae Terrisse, Lisa Derosa, Valerio Iebba, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 9, pp. 2778-2796
Open Access | Times Cited: 125
Metronomic Chemotherapy
Marina Elena Cazzaniga, Nicoletta Cordani, Serena Capici, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2236-2236
Open Access | Times Cited: 66
Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth
Alastair M. McKee, Benjamin Kirkup, Matthew Madgwick, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 103012-103012
Open Access | Times Cited: 59
Effects of microbiota on anticancer drugs: Current knowledge and potential applications
Jiayuan Huang, Wenting Liu, Wanying Kang, et al.
EBioMedicine (2022) Vol. 83, pp. 104197-104197
Open Access | Times Cited: 55
The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
Deeptashree Nandi, Sheetal Parida, Dipali Sharma
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 38
Human gut, breast, and oral microbiome in breast cancer: A systematic review and meta-analysis
May Soe Thu, Korn Chotirosniramit, Tanawin Nopsopon, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 26
Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation
Jiyan Su, Xiaojie Lin, Dan Li, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
Marine Fidelle, Satoru Yonekura, Marion Picard, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 69
Modulating Microbiota as a New Strategy for Breast Cancer Prevention and Treatment
Huixin Wu, Sebanti Ganguly, Trygve O. Tollefsbol
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1727-1727
Open Access | Times Cited: 35
Mendelian randomization analysis revealed a gut microbiota–mammary axis in breast cancer
Shuwan Zhang, Wenchuan Zhang, Haiyue Ren, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 17
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer
Rama Rao Malla, Rakshmitha Marni, Seema Kumari, et al.
Clinical Breast Cancer (2021) Vol. 22, Iss. 3, pp. 200-211
Closed Access | Times Cited: 38
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review
Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 38
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
Romy Aarnoutse, Janine Ziemons, Lars E. Hillege, et al.
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 28
The conundrum of breast cancer and microbiome - A comprehensive review of the current evidence
Andri Papakonstantinou, Paolo Nucíforo, María Borrell, et al.
Cancer Treatment Reviews (2022) Vol. 111, pp. 102470-102470
Closed Access | Times Cited: 27
Microbiome and cancer: from mechanistic implications in disease progression and treatment to development of novel antitumoral strategies
Marian Constantin, Mariana Carmen Chifiriuc, Grigore Mihăescu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Exploring the impact of gut microbiota and diet on breast cancer risk and progression
Nancy M. Y. Teng, Christopher A. Price, Alastair M. McKee, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 3, pp. 494-504
Open Access | Times Cited: 32
Identifying distinctive tissue and fecal microbial signatures and the tumor-promoting effects of deoxycholic acid on breast cancer
Na Wang, Jun Yang, Wenjie Han, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 20
The immunoregulatory role of gut microbiota in the incidence, progression, and therapy of breast cancer
Kaiyang Xue, Jiawei Li, Ruijie Huang
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
Gut microbiota interact with breast cancer therapeutics to modulate efficacy
Alana A. Arnone, Katherine Ansley, Arielle L. Heeke, et al.
EMBO Molecular Medicine (2025)
Open Access
Effect of Chemotherapy on the Gut Microbiome of Breast Cancer Patients During the First Year of Treatment
Anna H. Wu, Cheryl Vigen, Chiu-Chen Tseng, et al.
Breast Cancer Targets and Therapy (2022) Vol. Volume 14, pp. 433-451
Open Access | Times Cited: 17
Exploring the relationship between gut microbiota and breast cancer risk in European and East Asian populations using Mendelian randomization
Lin Wei, Chenghao Gu, Zheyin Chen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications
Francesco Schettini, Federica Gattazzo, Sabrina Nucera, et al.
Cancer Treatment Reviews (2024) Vol. 130, pp. 102816-102816
Open Access | Times Cited: 3
Fecal microbiota transplantation enhanced the effect of chemoimmunotherapy by restoring intestinal microbiota in LLC tumor-bearing mice
Xinmeng Wang, Qian Geng, Hua Jiang, et al.
BMC Immunology (2025) Vol. 26, Iss. 1
Open Access
Understanding and harnessing triple-negative breast cancer-related microbiota in oncology
Ciarán Devoy, Yensi Flores Bueso, Mark Tangney
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Exploring the Relationship between MicroRNAs, Intratumoral Microbiota, and Breast Cancer Progression in Patients with and without Metastasis
Aurora Laborda-Illanes, Lucía Aranega-Martín, Lidia Sánchez‐Alcoholado, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7091-7091
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top